Hyperechogenic fetal bowel: Current evidence-based prenatal diagnosis and management.

Autor: Vena F; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Mazza A; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy., Bartolone M; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Vasta A; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy., D'Alberti E; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy., Di Mascio D; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy., D'Ambrosio V; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy., Volpe G; Sapienza University of Rome, Rome, Italy., Signore F; Obstetrics and Gynecology Department, USL Roma 2, Sant'Eugenio Hospital, Rome, Italy., Pizzuti A; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Giancotti A; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.
Jazyk: angličtina
Zdroj: Journal of clinical ultrasound : JCU [J Clin Ultrasound] 2023 Sep; Vol. 51 (7), pp. 1172-1178. Date of Electronic Publication: 2023 Aug 08.
DOI: 10.1002/jcu.23528
Abstrakt: Echogenic fetal bowel (EB) is a prenatal ultrasound finding (0.2%-1.4% of all pregnancies) defined as bowel of similar or greater echogenicity than surrounding bone. In fact, the ultrasound assessment is strongly subjective with inter-observer variability. The pathophysiology depends on the underlying condition, apparently related with meconium stasis and hypercellularity. It is often an isolated finding, with possible association with other structural anomalies. About the origin, it was observed in fetuses with cystic fibrosis, congenital infections, thalassemia, intraamniotic bleeding, fetal growth restriction. Fetuses with EB are at increased risk of adverse perinatal outcome, such as intrauterine growth restriction, placental dysfunction and perinatal death, highlighting the need for a thorough antenatal management and post-natal follow-up. It seems to be associated with a plenty of conditions, such as a poor fetal outcome, fetal growth restriction and placental dysfunction. Therefore management requires a multidisciplinary approach with different specialties' involvement and the prognosis is influenced by the underlying pathophysiology. In this complex scenario, the present review aims to define the clinical pathway which should be offered to pregnant women in case of finding of fetal EB ultrasound marker, to rule out any suspected pathological cause.
(© 2023 The Authors. Journal of Clinical Ultrasound published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: